Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term ADJUVANT CHEMOTHERAPY. Found 10 abstracts

Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Annals of Oncology. 2009 Jul;20(7):1242-8.   PMCID: PMC2699385
Kim HJ, Barsevick AM, Tulman L. Predictors of the Intensity of Symptoms in a Cluster in Patients With Breast Cancer. Journal of Nursing Scholarship. 2009 Jan;41(2):158-65.   PMCID: PMC2884278
Waldman SA, Hyslop T, Schulz S, Barkun A, Nielsen K, Haaf J, Bonaccorso C, Li YY, Weinberg DS. Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer. JAMA-Journal of the American Medical Association. 2009 Feb;301(7):745-52.   PMCID: PMC 2756012
Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer. Journal of Clinical Oncology. 2008 Dec;26(34):5553-60.
Kim HJ, Barsevick AM, Tulman L, McDermott PA. Treatment-Related Symptom Clusters in Breast Cancer: A Secondary Analysis. Journal of Pain and Symptom Management. 2008 Nov;36(5):468-79.
Bukowski RM, Ozols RF, Markman M. The management of recurrent ovarian cancer. Seminars in Oncology. 2007 Apr;34(2):S1-S15.
Gridelli C, Langer C, Maione P, Rossi A, Schild SE. Lung cancer in the elderly. Journal of Clinical Oncology. 2007 May;25(14):1898-907.
Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA. HER2 and response to paclitaxel in node-positive breast cancer. New England Journal of Medicine. 2007 Oct;357(15):1496-506.
Punglia RS, Morrow M, Winer EP, Harris JR. Current concepts: Local therapy and survival in breast cancer. New England Journal of Medicine. 2007 Jun;356(23):2399-405.
Barsevick AM, Dudley W, Beek S, Sweeney C, Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004 Mar;100(6):1302-10.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term ADJUVANT CHEMOTHERAPY

ADJUVANT CHEMOTHERAPY THERAPY QUALITY-OF-LIFE WOMEN RANDOMIZED-TRIAL LUNG-CANCER FATIGUE TRIAL symptom management DIAGNOSIS PHASE-II TRIAL symptom clusters SYSTEMIC THERAPY C-ERBB-2 EXPRESSION GEMCITABINE PLUS VINORELBINE GROWTH-FACTOR GYNECOLOGIC-ONCOLOGY-GROUP GENE-EXPRESSION MECHANISM breast cancer CONSENSUS HIGH-DOSE CHEMOTHERAPY PROGNOSIS DOSE INTENSITY chemotherapy fatigue PHYSICAL PERFORMANCE NEU REFRACTORY OVARIAN YOUNG-PATIENTS BREAST-CANCER COMPLETE RESPONSE PATIENTS PREFERENCES Symptom clusters POSTOPERATIVE RADIOTHERAPY MULTIPLE-SCLEROSIS HIGHLIGHTS THORACIC PRIMARY PERITONEAL STATISTICS LEUKEMIA GROUP-B quality of life PLUS CISPLATIN CARCINOMA CONSERVING THERAPY PREDICT RESPONSE ADVANCED SOLID TUMORS ADVANCED ESOPHAGOGASTRIC CANCER NUMBER RADIATION-THERAPY breast neoplasm Symptom clusters-treatment-symptom management-symptom assessment-biological basis irinotecan GASTROESOPHAGEAL ADENOCARCINOMA STEM-CELL TRANSPLANTATION KeyWords Plus: esophageal cancer STAGE-II PREDICT RECURRENCE DOCETAXEL CELLS DUKES-B CLINICAL-TRIALS COMMUNITY ONCOLOGY PATHOLOGISTS GUIDELINE RECOMMENDATIONS MESSENGER-RNA NEOPLASM RADIOTHERAPY treatment ADVANCED GASTRIC-CANCER docetaxel MICROMETASTASES LOW-DOSE CARBOPLATIN PREMENOPAUSAL WOMEN COMBINATION CHEMOTHERAPY II COLON-CANCER DISTRESS DNA TOPOISOMERASE-I SELF-CARE VALIDATION ALPHA-FOLATE RECEPTOR HER-2 CISPLATIN-BASED THERAPY TAMOXIFEN TRASTUZUMAB RECEPTOR symptom assessment COMBINED-MODALITY OBSTRUCTIVE PULMONARY-DISEASE 2-STAGE DESIGNS SURVIVORS TUMOR RECURRENCE GUANYLYL CYCLASE-C predictors
Last updated on Thursday, April 02, 2020